AU1398395A - Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 - Google Patents

Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4

Info

Publication number
AU1398395A
AU1398395A AU13983/95A AU1398395A AU1398395A AU 1398395 A AU1398395 A AU 1398395A AU 13983/95 A AU13983/95 A AU 13983/95A AU 1398395 A AU1398395 A AU 1398395A AU 1398395 A AU1398395 A AU 1398395A
Authority
AU
Australia
Prior art keywords
propenoates
leukotriene
homologs
diphenyl
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13983/95A
Inventor
Robert A Daines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1398395A publication Critical patent/AU1398395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/75—Reactions with formaldehyde

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU13983/95A 1993-12-09 1994-12-05 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 Abandoned AU1398395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16460493A 1993-12-09 1993-12-09
US164604 1993-12-09
PCT/US1994/013966 WO1995015752A1 (en) 1993-12-09 1994-12-05 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4

Publications (1)

Publication Number Publication Date
AU1398395A true AU1398395A (en) 1995-06-27

Family

ID=22595252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13983/95A Abandoned AU1398395A (en) 1993-12-09 1994-12-05 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4

Country Status (8)

Country Link
EP (1) EP0732919A4 (en)
JP (1) JPH09506366A (en)
CN (1) CN1139880A (en)
AU (1) AU1398395A (en)
CA (1) CA2178634A1 (en)
NZ (1) NZ278484A (en)
WO (1) WO1995015752A1 (en)
ZA (1) ZA949786B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
EP2272817A4 (en) * 2008-04-11 2011-12-14 Inst Med Molecular Design Inc Pai-1 inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3244493A (en) * 1991-12-06 1993-06-28 Smithkline Beecham Corporation Heterocyclic-substituted pyridine compounds and uses
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds

Also Published As

Publication number Publication date
NZ278484A (en) 1998-02-26
EP0732919A1 (en) 1996-09-25
CA2178634A1 (en) 1995-06-15
ZA949786B (en) 1995-10-11
JPH09506366A (en) 1997-06-24
EP0732919A4 (en) 1997-05-02
WO1995015752A1 (en) 1995-06-15
CN1139880A (en) 1997-01-08

Similar Documents

Publication Publication Date Title
AU4861493A (en) Clear leave-on treatment composition and method
AU2187992A (en) Composition and method for disease treatment
AU7791594A (en) Illuminator and method for photodynamic therapy
AU6344794A (en) Consolidatable particulate material and well treatment method
EP0829323A3 (en) Infrared heater
AU2480195A (en) Polymerizable composition and organic glass
AU6916694A (en) Novel treatments for allergic diseases
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3192095A (en) Triazine derivative and medicine
AU5315394A (en) Method for crack prevention in bamboo canes
AU4929196A (en) Method of treating conditions associated with burn injuries
AU5644494A (en) Surface treated applicators and related methods
AU4520893A (en) Sterilization process and composition
AU6438094A (en) Coumarin derivative and use thereof
AU7969994A (en) Keratorefractive system and method
IL107763A0 (en) Infrared microscope
AU4055793A (en) Phacoemulsification method and tip
AU6368394A (en) Polymer-polypeptide composition and method
AU1398395A (en) Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
AU4364693A (en) Surfacing composition and method
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU1072395A (en) Mutated hig-e fragments and derivative thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU3734793A (en) Mutant gpibalpha fragments and recombinant expression thereof
AU7605394A (en) Neural tissue affecting factor and compositions